AMERICAN REBEL HOLDINGS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMERICAN REBEL HOLDINGS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $986.8K | Mar 31, 2022 |
| FY2021 | Dec 31, 2020 | $1.26M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $535.1K | May 24, 2021 |
| FY2019 | Jun 30, 2019 | $59.0K | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | $131.3K | May 18, 2020 |
| FY2019 | Jun 30, 2018 | $31.2K | Oct 3, 2019 |
| FY2018 | Dec 31, 2017 | $46.4K | Apr 5, 2019 |
| FY2017 | Dec 31, 2016 | $7.1K | May 21, 2018 |
| FY2016 | Dec 31, 2015 | $0 | Mar 13, 2017 |
| FY2015 | Dec 31, 2014 | $0 | Mar 1, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.52M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.42M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $16.00M | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | $7.95M | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | $986.8K | Apr 14, 2023 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($197.8K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($119.6K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.80M | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | ($807.0K) | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | $174.7K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $303.2K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $156.0K | May 24, 2021 |
| FY2019 | Jun 30, 2019 | $16.1K | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | $75.5K | May 18, 2020 |
| FY2019 | Jun 30, 2018 | $18.0K | Oct 3, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($34.33M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($17.60M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($9.73M) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | ($10.09M) | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | ($6.10M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($5.98M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($7.60M) | May 24, 2021 |
| FY2019 | Jun 30, 2019 | ($966.1K) | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | ($2.00M) | May 18, 2020 |
| FY2019 | Jun 30, 2018 | ($483.0K) | Oct 3, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($14.76M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($12.22M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($8.76M) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | ($8.00M) | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | ($3.31M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($2.77M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($6.00M) | May 24, 2021 |
| FY2019 | Jun 30, 2019 | ($741.1K) | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | ($1.71M) | May 18, 2020 |
| FY2019 | Jun 30, 2018 | ($416.7K) | Oct 3, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.6K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $385.8K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $132.5K | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | $746.9K | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | $330.4K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $320.5K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $309.1K | May 24, 2021 |
| FY2019 | Jun 30, 2019 | $182.8K | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | $23.6K | May 18, 2020 |
| FY2019 | Jun 30, 2018 | $7.9K | Oct 3, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.22M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($7.02M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($7.03M) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | ($7.63M) | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | ($847.8K) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($1.97M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($2.18M) | May 24, 2021 |
| FY2019 | Jun 30, 2019 | ($978.8K) | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | ($1.44M) | May 18, 2020 |
| FY2019 | Jun 30, 2018 | ($638.0K) | Oct 3, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $329.4K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $3.1K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $6.3K | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | $30.4K | Jan 29, 2025 |
| FY2020 | Dec 31, 2020 | $0 | May 24, 2021 |
| FY2020 | Dec 31, 2019 | $0 | May 24, 2021 |
| FY2019 | Jun 30, 2019 | $0 | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | $0 | May 18, 2020 |
| FY2019 | Jun 30, 2018 | $0 | Oct 3, 2019 |
| FY2018 | Dec 31, 2017 | $18.0K | Apr 5, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.82M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $10.01M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $11.55M | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | $12.55M | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | $968.6K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.12M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.87M | May 24, 2021 |
| FY2019 | Jun 30, 2019 | $928.2K | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | $1.04M | May 18, 2020 |
| FY2018 | Dec 31, 2017 | $935.5K | Apr 5, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.44M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $17.64M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $7.47M | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | $4.89M | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | $5.14M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $6.13M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $4.82M | May 24, 2021 |
| FY2019 | Jun 30, 2019 | $3.14M | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | $1.91M | May 18, 2020 |
| FY2018 | Dec 31, 2017 | $3.17M | Apr 5, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.38M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($7.63M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $4.07M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $7.66M | Apr 9, 2025 |
| FY2023 | Dec 31, 2021 | ($4.86M) | Jan 29, 2025 |
| FY2022 | Dec 31, 2020 | ($5.01M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2019 | ($2.95M) | Mar 31, 2022 |
| FY2019 | Jun 30, 2019 | ($2.22M) | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | ($870.3K) | May 18, 2020 |
| FY2018 | Dec 31, 2017 | ($2.24M) | Apr 5, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.00M | Apr 12, 2024 |
| FY2023 | Dec 31, 2022 | $4.20M | Apr 12, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($99.41M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($65.09M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($47.48M) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | ($37.75M) | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | ($26.97M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($20.87M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($14.89M) | May 24, 2021 |
| FY2019 | Jun 30, 2019 | ($9.01M) | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | ($7.29M) | May 18, 2020 |
| FY2018 | Dec 31, 2017 | ($5.29M) | Apr 5, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $147.6K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $287.5K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.08M | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | $286.1K | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | $17.6K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $60.9K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $131.7K | May 24, 2021 |
| FY2019 | Jun 30, 2019 | $26.2K | Oct 3, 2019 |
| FY2020 | Dec 31, 2018 | $19.6K | May 24, 2021 |
| FY2019 | Jun 30, 2018 | $32.9K | Oct 3, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $3.88M | Mar 31, 2022 |
| FY2021 | Dec 31, 2020 | $4.67M | Mar 31, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (63,214) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (12.28M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (857) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | (33) | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | (4) | Apr 14, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (63,214) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (12.28M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (857) | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | (33) | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | (3) | Apr 14, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,362 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 26,133 | Apr 9, 2025 |
| FY2023 | Dec 31, 2022 | 677,221 | Jan 29, 2025 |
| FY2022 | Dec 31, 2021 | 1.60M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | 910,100 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 43.06M | May 24, 2021 |
| FY2019 | Jun 30, 2019 | 30.31M | Oct 3, 2019 |
| FY2019 | Dec 31, 2018 | 29.91M | May 18, 2020 |
| FY2018 | Dec 31, 2017 | 23.77M | Apr 5, 2019 |